SAMDaily.us | PRESOL | A | Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method.

SAMDAILY.US - ISSUE OF AUGUST 27, 2022 SAM #7575
SOLICITATION NOTICE

A -- Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method.

Notice Date: 8/25/2022 6:10:34 AM
Notice Type: Combined Synopsis/Solicitation
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Silver Spring MD 20993 USA
ZIP Code: 20993
Solicitation Number: FDARFP1258398A
Response Due: 8/29/2022 11:00:00 AM
Archive Date: 09/13/2022
Point of Contact: Howard S Yablon, Phone: 2404027630
E-Mail Address: howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
Description: Perform an interlaboratory reproducibility study and obtain experimental data to identify specific organism/drug combinations that may exhibit biological variability when testing is performed using the CLSI BMD method. See Attachment 1 for RFP See Attachment 2 for SOW See Attachment 3 for IPP Invoicing Instructions Proposal Due Date extended to August 29, 2022, 2:00 PM ET. See Attachment for Contractors' Questions and Government Responses
Web Link: SAM.gov Permalink
(https://sam.gov/opp/5cbe8112a5e54d21a4212f588da97aff/view)
Place of Performance: Address: MD 20993, USA; Zip Code: 20993; Country: USA
Record: SN06440573-F 20220827/220825230123 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |